Endurant Capital Management as of June 30, 2021
Portfolio Holdings for Endurant Capital Management
Endurant Capital Management holds 57 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Invacare Corp Note 5.000%11/1 | 10.1 | $37M | 38M | 0.98 | |
| Laboratory Corp Amer Hldgs Com New (LH) | 4.8 | $17M | 63k | 275.85 | |
| Cigna Corp (CI) | 4.7 | $17M | 72k | 237.07 | |
| Icon SHS (ICLR) | 4.5 | $16M | 79k | 206.71 | |
| Thermo Fisher Scientific (TMO) | 4.1 | $15M | 30k | 504.46 | |
| Tenet Healthcare Corp Com New (THC) | 4.0 | $15M | 218k | 66.99 | |
| R1 Rcm | 3.4 | $12M | 549k | 22.24 | |
| Syneos Health Cl A | 3.2 | $12M | 130k | 89.49 | |
| Invacare Corporation | 3.1 | $11M | 2.1M | 5.44 | |
| Abbvie (ABBV) | 2.6 | $9.6M | 86k | 112.64 | |
| Aziyo Biologics Com Cl A (ELUT) | 2.3 | $8.4M | 873k | 9.61 | |
| Ocular Therapeutix (OCUL) | 2.2 | $8.1M | 571k | 14.18 | |
| Phasebio Pharmaceuticals (PHASQ) | 2.2 | $7.9M | 2.1M | 3.72 | |
| Haemonetics Corporation (HAE) | 2.2 | $7.9M | 118k | 66.64 | |
| Eargo | 2.1 | $7.7M | 194k | 39.91 | |
| Bio Rad Labs Cl A (BIO) | 2.1 | $7.6M | 12k | 644.33 | |
| Insmed Com Par $.01 (INSM) | 2.0 | $7.4M | 260k | 28.46 | |
| Hologic (HOLX) | 2.0 | $7.4M | 111k | 66.72 | |
| Humana (HUM) | 1.9 | $7.0M | 16k | 442.72 | |
| Bristol Myers Squibb (BMY) | 1.9 | $6.8M | 101k | 66.82 | |
| Dentsply Sirona (XRAY) | 1.8 | $6.6M | 104k | 63.26 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 1.8 | $6.6M | 1.5M | 4.26 | |
| Molecular Templates | 1.6 | $5.8M | 748k | 7.82 | |
| Trillium Therapeutics Com New | 1.6 | $5.8M | 601k | 9.70 | |
| Veracyte (VCYT) | 1.5 | $5.6M | 140k | 39.98 | |
| Insmed Note 0.750% 6/0 | 1.5 | $5.5M | 5.0M | 1.11 | |
| Dariohealth Corp Com New (DRIO) | 1.5 | $5.5M | 259k | 21.36 | |
| Johnson & Johnson (JNJ) | 1.5 | $5.4M | 33k | 164.74 | |
| Avantor (AVTR) | 1.5 | $5.4M | 152k | 35.51 | |
| AmerisourceBergen (COR) | 1.3 | $4.8M | 42k | 114.50 | |
| Anthem (ELV) | 1.3 | $4.6M | 12k | 381.79 | |
| Fate Therapeutics (FATE) | 1.2 | $4.4M | 51k | 86.79 | |
| Silverback Therapeutics (SPRY) | 1.2 | $4.3M | 139k | 30.89 | |
| Calliditas Therapeutics Ab Sponsered Ads (CALT) | 1.2 | $4.3M | 144k | 29.45 | |
| Iovance Biotherapeutics (IOVA) | 1.1 | $4.2M | 160k | 26.02 | |
| Selecta Biosciences (RNAC) | 1.1 | $3.9M | 927k | 4.18 | |
| Praxis Precision Medicines I | 1.0 | $3.6M | 200k | 18.28 | |
| Albireo Pharma | 1.0 | $3.6M | 104k | 35.18 | |
| Medavail Holdings Ord | 1.0 | $3.6M | 292k | 12.25 | |
| Regeneron Pharmaceuticals (REGN) | 0.9 | $3.1M | 5.6k | 558.51 | |
| Teleflex Incorporated (TFX) | 0.8 | $3.0M | 7.5k | 401.81 | |
| Owens & Minor (OMI) | 0.8 | $2.8M | 67k | 42.34 | |
| Mereo Biopharma Group Ads (MREO) | 0.7 | $2.4M | 757k | 3.17 | |
| Sarepta Therapeutics (SRPT) | 0.6 | $2.2M | 29k | 77.73 | |
| Immunic (IMUX) | 0.6 | $2.2M | 177k | 12.26 | |
| Regulus Therapeutics Com New | 0.6 | $2.1M | 2.6M | 0.81 | |
| Aclaris Therapeutics (ACRS) | 0.6 | $2.1M | 119k | 17.56 | |
| Baxter International (BAX) | 0.6 | $2.0M | 25k | 80.49 | |
| Pennant Group (PNTG) | 0.5 | $1.9M | 48k | 40.91 | |
| Forte Biosciences (FBRX) | 0.5 | $1.8M | 53k | 33.62 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.4 | $1.5M | 7.6k | 201.64 | |
| Bellus Health Com New | 0.3 | $1.3M | 407k | 3.11 | |
| Si-bone (SIBN) | 0.3 | $1.3M | 40k | 31.48 | |
| Celyad Oncology Sa Adr | 0.2 | $845k | 161k | 5.26 | |
| Cano Health Com Cl A | 0.2 | $750k | 62k | 12.09 | |
| Provention Bio | 0.2 | $699k | 83k | 8.43 | |
| X4 Pharmaceuticals (XFOR) | 0.1 | $461k | 71k | 6.50 |
